Archives for July 18, 2016

← 2016

Update: Sandoz remains committed to launching 5 biosims by 2020

US FDA rejects Sandoz’s Neulasta biosimilar

By Gareth Macdonald

The US FDA has issued Sandoz with a complete response letter for its Neulasta biosimilar.

FDA adds 4 API manufacturers to 'Red List'

By Melissa Fassbender

Two Chinese and two Indian companies have been banned from importing APIs to the US – one manufacturer says it’s making GMP compliance a “priority.”